Robert Alexander Ingram is an American businessperson who founded CEO Roundtable on Cancer, Inc. and who has been at the head of 21 different companies. Mr. Ingram is Chairman for BioCryst Pharmaceuticals, Inc., Chairman at Viamet Pharmaceuticals Corp., Chairman for Viamet Pharmaceuticals, Inc. (a subsidiary of Viamet Pharmaceuticals Corp.), Chairman at Research Triangle Foundation, Chairman at Black Diamond Therapeutics, Inc. and General Partner for Hatteras Venture Partners. Robert Alexander Ingram is also on the board of H. Lee Moffitt Cancer Center & Research Institute, Inc., American Cancer Society Foundation (former Chairman), CEO Roundtable on Cancer, Inc. (former Chairman) and James B. Hunt, Jr. Institute for Educational Leadership & Poli and Chairman of GlaxoSmithKline Foundation, Chairman at North Carolina Glaxosmithkline Foundation, Member-Governors Board at Research Triangle Institute and Member of Business-Higher Education Forum.
In his past career he was Chairman for Wolfspeed, Inc., Independent Director at Novan, Inc., Chairman at Serenity Pharmaceuticals Corp., Chairman for Bausch Health Cos., Inc., Director at Lowe's Cos., Inc., Non-Executive Chairman for Elan Corp. Plc, Chairman of OSI Pharmaceuticals, Inc., Chairman & Chief Executive Officer for Glaxo Wellcome Plc, Chairman for Elan Pharmaceuticals, LLC, Chairman, President & Chief Executive Officer at Glaxo Wellcome, Inc., Chairman at Glaxo, Inc., President at Merck Frosst Canada Ltd., Vice Chairman-Pharmaceuticals at GlaxoSmithKline LLC, Principal at National Institutes of Health, Vice President-Public Affairs at Merrell Dow Pharmaceuticals, Inc. and Chairman at American Foundation for Pharmaceutical Education.
Mr. Ingram received an undergraduate degree from Eastern Illinois University.